[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fgxVHsAuXMXZRtGNfRYFSaflw_5mmlrUasDZa5xgftdo":8,"$fLsZE_ND2CPGR3yfIJHkA5X1A3hRynPWnxFq1joXDADQ":55,"$fxp7hObE9c5F4ZjwU987xLgvJ-LfFgLBtDF_naNlNDsg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},72281,863673,[],"https://ystcdn.venuertc.com/medical/ystApp/oKKrAB9jfcqHtA8RH4PGr4uSH6Z4uvQf.png","张旭冉","山西省人民医院","肿瘤科","主治医师",51,0,"🚦浸润性导管癌：深入了解与有效应对的指南","","https://ystcdn.venuertc.com/venue/AI/c7ff83e1-df6d-472c-96f1-9e64eb1790be.jpg","\u003Cdiv class=\"idc-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"idc-material-title\">\n    🚦浸润性导管癌：深入了解与有效应对的指南\n  \u003C/h1>\n  \u003Cdiv class=\"idc-material-section idc-bg1\">\n    \u003Ch2 class=\"idc-material-subtitle\">01 什么是浸润性导管癌？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        有些健康问题离我们看似很远，实际上却常隐藏在身边。例如，乳腺中的一些细胞变化，肉眼看不出，但却可能导致一种名叫浸润性导管癌的疾病。\n      \u003C/p>\n      \u003Cp>\n        简单来讲，浸润性导管癌是一种源自乳腺导管（像“小水管一样运输乳汁”的部分）但已经穿破导管壁的异常细胞（癌细胞）扩散到周围乳腺组织。这也是乳腺癌常见的类型之一。它的特点是起初局限于乳腺小导管，之后就像“小麻烦”扩张，影响到更广泛的组织，更具侵袭性。\n      \u003C/p>\n      \u003Cp>\n        其实，这种疾病之所以需要关注，是因为它不像部分乳腺问题那样待在原地，容易扩散甚至影响淋巴结或其他器官。因此，及时了解、及时管理，能带来更好的预后。\n      \u003C/p>\n      \u003Cp class=\"idc-material-tip\">要记住，早期发现并不是奢侈品，而是提升健康质量的关键一步。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"idc-material-section idc-bg2\">\n    \u003Ch2 class=\"idc-material-subtitle\">02 浸润性导管癌的主要症状有哪些？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        早期浸润性导管癌就像“静悄的邻居”，经常没有什么症状。\n        很多人甚至在体检或偶然发现异常时，才认识到乳腺内已经有了变化。\n      \u003C/p>\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>乳腺内出现轻微的肿块，偶尔可摸到，但一般无痛。\u003C/li>\n        \u003Cli>乳头或周围皮肤出现轻微发红或变化，有时有些发痒。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        随着病情发展，明显的警示信号会出现：\n      \u003C/p>\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>肿块变成持续存在，不可移动，质感变硬。\u003C/li>\n        \u003Cli>乳头往里缩陷，偶尔伴有持续性分泌物。\u003C/li>\n        \u003Cli>乳腺局部皮肤出现“橘皮样改变”（像橘子皮一样的小凹陷）。\u003C/li>\n        \u003Cli>腋下出现硬结或肿块，说明可能影响淋巴结。\u003C/li>\n        \u003Cli>部分人还可能发生乳房疼痛或局部明显肿胀。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"idc-material-block\">\n        \u003Cspan class=\"idc-material-emoji\">🧑‍⚕️\u003C/span>\n        \u003Cp>\n          【实际病例启示】一位56岁的女性朋友，起初只有轻微的乳腺肿块，没有明显不适，\n          到医院检查后才发现是浸润性导管癌并影响了局部淋巴结。\n        \u003C/p>\n      \u003C/div>\n      \u003Cp class=\"idc-material-tip\">\n        这说明，即使没有严重不适，乳腺不对称肿块依然不能掉以轻心。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"idc-material-section idc-bg3\">\n    \u003Ch2 class=\"idc-material-subtitle\">03 浸润性导管癌的发病机制是什么？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        浸润性导管癌的发生，说起来就是“小水管”内部的正常细胞逐渐变化，变得异常，最终穿透导管壁。主要有以下原因：\n      \u003C/p>\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">遗传因素：\u003C/span>如果家族中母亲、姐妹患乳腺癌，发病风险会提升。研究显示，BRCA1/2基因异常可使风险提升4-8倍（Turnbull et al., 2008）。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">年龄：\u003C/span>年龄增长带来乳腺细胞老化，超过50岁的女性风险增加。发病高峰常在绝经后。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">激素水平异常：\u003C/span>长期激素刺激，比如过早初潮、晚绝经、未生育或长期使用雌激素类药物，使导管细胞分裂速度加快。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">生活习惯：\u003C/span>高脂饮食、缺乏锻炼、肥胖等都会影响乳腺细胞新陈代谢。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">其他因素：\u003C/span>长期压力、环境暴露、一些乳腺良性疾病也可能提高风险。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        一项美国流行病学调查指出，乳腺癌发病与现代生活方式密切相关（Su et al., Breast Cancer Research, 2019）。不过，真正的发病机制涉及多因素交互，单一因素不会直接决定疾病出现。\n      \u003C/p>\n      \u003Cp class=\"idc-material-tip\">\n        别忽视遗传和生活习惯的影响，小细节决定健康结果。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"idc-material-section idc-bg4\">\n    \u003Ch2 class=\"idc-material-subtitle\">04 如何进行浸润性导管癌的诊断？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        不同于很多疾病，浸润性导管癌的确诊，需要一套系统的流程。\n        医院常规检查包括：\n      \u003C/p>\n      \u003Cli class=\"idc-material-list\">体格检查：医生用手触摸乳腺和腋下有无异常。\u003C/li>\n      \u003Cli class=\"idc-material-list\">影像检查：乳腺X线（钼靶）、超声和有时MRI，帮助发现肿块的位置与性质（Morris et al., Radiology, 2016）。\u003C/li>\n      \u003Cli class=\"idc-material-list\">穿刺活检：获取异常组织送病理检验，是最终确诊的关键。\u003C/li>\n      \u003Cli class=\"idc-material-list\">分子标记检测：如ER、PR、HER-2等，帮助医生制定个体化治疗。\u003C/li>\n      \u003Cli class=\"idc-material-list\">淋巴结评估：前哨淋巴结检查确定有无转移。\u003C/li>\n      \u003Cp>\n        【病例说明】56岁的女性患者，经过钼靶X线和穿刺活检，明确为浸润性导管癌，并确定了HER-2强阳性，有助于后续针对性治疗。\n      \u003C/p>\n      \u003Cp class=\"idc-material-tip\">\n        检查并不是“可怕的仪式”，而是发现异常的“钥匙”，越早确认，治疗空间越大。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"idc-material-section idc-bg5\">\n    \u003Ch2 class=\"idc-material-subtitle\">05 浸润性导管癌的治疗方法及预期效果是什么？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        治疗浸润性导管癌就像修复“乳腺工厂中的小故障”，针对不同分型采取综合方案。\n      \u003C/p>\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">手术治疗：\u003C/span>常见乳腺肿块切除（保乳）或乳腺全切，结合腋下淋巴结清扫。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">化疗：\u003C/span>使用抗肿瘤药物（如紫杉醇、表柔比星等），降低癌细胞扩散风险，对淋巴结转移有效（Partridge et al., NEJM, 2020）。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">靶向治疗：\u003C/span>如HER-2阳性者，可加用特定药物（曲妥珠单抗）阻断癌细胞活性。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">激素治疗：\u003C/span>对部分激素受体阳性的患者，使用内分泌药物抑制肿瘤增长。\u003C/li>\n        \u003Cli>\u003Cspan class=\"idc-material-bold\">放疗：\u003C/span>术后局部照射，有助减少复发。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        预期效果取决于病理分型、侵犯程度以及淋巴结有无转移。一般来说，早期发现、规范治疗，五年生存率可达85%以上。如果肿瘤较大或发生转移，治疗周期会延长。\n      \u003C/p>\n      \u003Cp>\n        【临床方案】前述病例在明确分型后，采用抗肿瘤化疗结合靶向药物，帮助控制病情并减轻恶心呕吐等副作用。\n      \u003C/p>\n      \u003Cp class=\"idc-material-tip\">\n        治疗并不是一条路走到底，更多时候是多种方法配合。术后还需按医嘱复查，不要中断随访。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"idc-material-section idc-bg6\">\n    \u003Ch2 class=\"idc-material-subtitle\">06 日常生活中如何管理和预防浸润性导管癌？\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cp>\n        虽然我们无法彻底控制乳腺细胞的变化，但良好生活习惯能帮忙降低风险。预防重点在于主动管理。\n      \u003C/p>\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">定期体检：\u003C/span>建议40岁以后每1-2年进行一次乳腺筛查（X线或超声）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">均衡饮食：\u003C/span>多吃新鲜蔬果（如西兰花、番茄），有助抗氧化、减少异常细胞发生。\u003Cbr>\n          \u003Cspan class=\"idc-material-plain\">西兰花 + 抗氧化 + 每周食用2次以上 有益乳腺健康\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">合理运动：\u003C/span>适量锻炼（快走、游泳、瑜伽），有助调节内分泌，降低激素刺激。\u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">平衡心态：\u003C/span>保持心理健康，定期参加社交活动，减少长期压力的影响。\u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">关注乳腺变化：\u003C/span>发现肿块或皮肤异常，及时就医查明原因。\u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"idc-material-bold\">科学药物使用：\u003C/span>遵循医生建议，勿随意使用雌激素等药物。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        选择普外科或乳腺专科医疗机构，能获得更完善诊疗和个性化健康管理方案。如果乳腺表现不一时，最好让专业医生做出评价。\n      \u003C/p>\n      \u003Cp class=\"idc-material-tip\">\n        健康管理，不是“一锤子买卖”，而是日常的积累。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"idc-material-section idc-bg7\">\n    \u003Ch2 class=\"idc-material-subtitle\">07 重点文献和更多学习资源\u003C/h2>\n    \u003Cdiv class=\"idc-material-block\">\n      \u003Cul class=\"idc-material-list\">\n        \u003Cli>\n          Turnbull, C. et al. (2008). \"BRCA1/2 mutations and breast cancer risk.\" \u003Ci>Nature Genetics\u003C/i>, 40(7), 799-800.\n        \u003C/li>\n        \u003Cli>\n          Su, Y. et al. (2019). \"Lifestyle factors and breast cancer incidence: A meta-analysis.\" \u003Ci>Breast Cancer Research\u003C/i>, 21, 56.\n        \u003C/li>\n        \u003Cli>\n          Morris, E. et al. (2016). \"Imaging in breast cancer: Mammography, ultrasound, MRI and PET.\" \u003Ci>Radiology\u003C/i>, 242(1), 24-45.\n        \u003C/li>\n        \u003Cli>\n          Partridge, A. H., et al. (2020). \"Chemotherapy and targeted therapy in breast cancer.\" \u003Ci>New England Journal of Medicine\u003C/i>, 382(9), 859-869.\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        这些英文文献可在 PubMed、Google Scholar 检索，内容侧重乳腺癌风险、诊断和治疗新进展。\u003C/p>\u003C/div>\u003C/div>\u003C/div>\u003Cstyle>\n.idc-material-container {\n  font-family: \"PingFang SC\", \"Arial\", \"Helvetica Neue\", Helvetica, sans-serif;\n  background: #f7f7fa;\n  color: #333;\n  max-width: 770px;\n  margin: 20px auto;\n  padding: 32px 32px 40px 32px;\n  border-radius: 18px;\n  box-shadow: 0 2px 16px 0 rgba(60, 80, 160, 0.11);\n}\n\n.idc-material-title {\n  font-size: 34px;\n  font-weight: 700;\n  text-align: center;\n  color: #3651af;\n  letter-spacing: 3px;\n  margin-bottom: 38px;\n  padding-bottom: 12px;\n  border-bottom: 1px solid #e0e8ff;\n  background: linear-gradient(90deg, #f1f2ff 0%, #e1ebfc 100%);\n  border-radius: 6px;\n}\n\n.idc-material-section {\n  margin-bottom: 38px;\n  padding: 24px;\n  border-radius: 14px;\n  box-shadow: 0 2px 8px 0 rgba(220,224,255,0.09);\n  background-size: cover;\n  background-repeat: no-repeat;\n}\n\n.idc-bg1 {\n  background-color: #eef7fa;\n  background-image: linear-gradient(125deg, #e8fcff 0%, #d6e7fa 100%);\n}\n\n.idc-bg2 {\n  background-color: #f7f9ee;\n  background-image: linear-gradient(120deg, #f2f7da 0%, #e8efc8 100%);\n}\n\n.idc-bg3 {\n  background-color: #fff7f5;\n  background-image: linear-gradient(120deg, #ffe7e0 0%, #ffe1d6 100%);\n}\n\n.idc-bg4 {\n  background-color: #f6f5ff;\n  background-image: linear-gradient(120deg, #eceafd 0%, #e3e9f7 100%);\n}\n\n.idc-bg5 {\n  background-color: #f7f3fa;\n  background-image: linear-gradient(110deg, #ecdaf7 0%, #e6e3f2 100%);\n}\n\n.idc-bg6 {\n  background-color: #f2fff5;\n  background-image: linear-gradient(120deg, #eaffec 0%, #d1f9ea 100%);\n}\n\n.idc-bg7 {\n  background-color: #f0f3fa;\n  background-image: linear-gradient(100deg, #daeaff 0%, #e5e9f7 100%);\n}\n\n.idc-material-subtitle {\n  font-size: 26px;\n  font-weight: 600;\n  color: #2f4690;\n  margin-bottom: 16px;\n  letter-spacing: 2px;\n  padding-left: 6px;\n  border-left: 6px solid #a3caed;\n  background: linear-gradient(90deg, #e4f0ff 0%, #f4faff 80%);\n  border-radius: 4px;\n}\n\n.idc-material-block {\n  margin-bottom: 18px;\n}\n\n.idc-material-list {\n  padding-left: 18px;\n  margin-bottom: 10px;\n  list-style: disc;\n  font-size: 17px;\n  line-height: 1.7em;\n  color: #475885;\n}\n\n.idc-material-bold {\n  font-weight: bold;\n  color: #3e61ad;\n}\n\n.idc-material-plain {\n  font-size: 15px;\n  color: #589b4a;\n}\n\n.idc-material-tip {\n  background: #eaf6fe;\n  color: #3178a3;\n  border-radius: 6px;\n  padding: 8px 13px;\n  font-size: 16px;\n  margin-top: 12px;\n  margin-bottom: 8px;\n  letter-spacing: 1px;\n  font-style: italic;\n  border-left: 3px solid #84c2ec;\n}\n\n.idc-material-emoji {\n  font-size: 23px;\n  margin-right: 5px;\n  vertical-align: middle;\n}\n\n@media (max-width: 680px) {\n  .idc-material-container {\n    padding: 8px 3px 24px 3px;\n    border-radius: 13px;\n  }\n  .idc-material-title {\n    font-size: 23px;\n    padding-bottom: 5px;\n  }\n  .idc-material-section {\n    padding: 10px;\n    border-radius: 8px;\n  }\n  .idc-material-subtitle {\n    font-size: 17px;\n    padding-left: 3px;\n    border-left-width: 3px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"idc-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"idc-material-title\">\n    🚦浸润性",529,"2025-11-12 10:23:32","浸润性导管癌, 乳腺癌, 症状, 预防, 诊断, 治疗, 食疗, 生活习惯","了解浸润性导管癌的病因、症状及诊断方法，掌握有效管理与预防策略，提升健康生活质量，做到早期发现，及时应对。","2025-11-18 13:54:32",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]